UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience

Gynécologie, obstétrique & fertilité, 2015-12, Vol.43 (12), p.780-785

2015

Volltextzugriff (PDF)

Cell-free translation of messenger RNAs from human muscle biopsies: a miniaturized tool for investigation of neuromuscular diseases

Pediatric research, 1982-05, Vol.16 (5), p.335-339

1982

Volltextzugriff (PDF)

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques

Annals of human genetics, 1981-05, Vol.45 (2), p.113-120

1981

Volltextzugriff (PDF)

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Journal of clinical oncology, 2013-07, Vol.31 (19), p.2428-2436

2013

Volltextzugriff (PDF)

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3322-3327

2011

Volltextzugriff (PDF)

Muscle-type phosphorylase activity present in muscle cells cultured from three patients with myophosphorylase deficiency

Archives of neurology (Chicago), 1977-12, Vol.34 (12), p.779-781

1977

Volltextzugriff (PDF)

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Leukemia, 2011-07, Vol.25 (7), p.1147-1152

2011

Volltextzugriff (PDF)

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Neurology, 2013-05, Vol.80 (19), p.1784-1791

2013

Volltextzugriff (PDF)

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Haematologica (Roma), 2010-03, Vol.95 (3), p.415-423

2010

Volltextzugriff (PDF)

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

Leukemia, 2013-10, Vol.27 (10), p.1981-1987

2013

Volltextzugriff (PDF)

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Haematologica (Roma), 2009-12, Vol.94 (12), p.1676-1681

2009

Volltextzugriff (PDF)

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Leukemia, 2010-05, Vol.24 (5), p.1094-1096

2010

Volltextzugriff (PDF)

Assessment of Chronic Pain After Thoracotomy: A 1-Year Prevalence Study

The Clinical journal of pain, 2011-10, Vol.27 (8), p.677-681

2011

Volltextzugriff (PDF)

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9227-9233

2005

Volltextzugriff (PDF)

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Nature Medicine, 2020-03, Vol.26 (3), p.398-407

2020

Volltextzugriff (PDF)

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

American journal of obstetrics and gynecology, 2021-07, Vol.225 (1), p.51.e1-51.e17

2021

Volltextzugriff (PDF)

Prevalence of insomnia in a survey of 12 778 adults in France

Journal of sleep research, 2000-03, Vol.9 (1), p.35-42

2000

Volltextzugriff (PDF)

Antegrade cerebral perfusion with cold blood: a 13-year experience

The Annals of thoracic surgery, 1999-06, Vol.67 (6), p.1874-1878

1999

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionSpringerLink (Online service)

Nur zeigenMit Volltextzugriff

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)

Publikationsform

Artikel
(273)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience

Cell-free translation of messenger RNAs from human muscle biopsies: a miniaturized tool for investigation of neuromuscular diseases

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Muscle-type phosphorylase activity present in muscle cells cultured from three patients with myophosphorylase deficiency

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

Assessment of Chronic Pain After Thoracotomy: A 1-Year Prevalence Study

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

Prevalence of insomnia in a survey of 12 778 adults in France

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Antegrade cerebral perfusion with cold blood: a 13-year experience

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Aktive Filter

Suchergebnisse filtern